Generic placeholder image

Current Pharmaceutical Biotechnology


ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Approaches to Education of Pharmaceutical Biotechnology in Faculties of Pharmacy

Author(s): Sema Calis, Filiz Oner, Suheyla Kas and Atilla A. Hincal

Volume 2, Issue 2, 2001

Page: [143 - 155] Pages: 13

DOI: 10.2174/1389201013378761

Price: $65


Pharmaceutical biotechnology is developing rapidly both in academic institutions and in the biopharmaceutical industry. For this reason, FIP Special Interest Group of Pharmaceutical Biotechnology decided to develop a questionnaire concerning pharmaceutical biotechnology education. After preliminary studies were completed, questionnaires were sent to the leading scientists in academia and research directors or senior managers of various Pharmaceutical Biotechnology Companies in order to gather their views about how to create a satisfactory program. The objectives of this study were as follows: -To review all of the graduate and undergraduate courses which are presently available worldwide on pharmaceutical biotechnology in Faculties of Pharmacy. -To review all of the text books, references and scientific sources available worldwide in the area of pharmaceutical biotechnology . When replying to the questionnaires, the respondents were asked to consider the present status of pharmaceutical biotechnology education in academia and future learning needs in collaboration with the biotechnology industry. The data from various pharmacy faculties and biotechnology industry representatives from Asia, Europe and America were evaluated and the outcome of the survey showed that educational efforts in training qualified staff in the rapidly growing field of pharmaceutical biotechnology is promising. Part of the results of this questionnaire study have already been presented at the 57 th International Congress of FIP Vancouver, Canada in 1997.

Keywords: Monoclonal Antibodies, Human Somatic Cell Culture, Biotechnology Products, Proteins, Vaccines, Genomics, Recombinant DNA Technology, HUMAN SOMATIC CELL GENE THERAPY

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy